Weitzman Deborah
Officer at CAH
- Sold, on record
- $9.4M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 18, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CAHCARDINAL HEALTH INCOfficer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 144 notice CAHNoticeAug 28, 2023 2023
Filed to sell 6,712 shares ($603k)
Weitzman Deborah, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale CAHNo planAug 28, 2023 same day
Sold 6,712 shares at $89.81 ($603k)
Weitzman Deborah, CEO, Pharmaceutical Segment
No 10b5-1 planSold 13.2% of holdings ($4.6M position)44,202 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice CAHNoticeNov 27, 2023 +91 days
Filed to sell 36,642 shares ($3.9M)
Weitzman Deborah, Officer
10b5-1 planFiling
- 4 Form 4 sale CAHRoutineNov 27, 2023 same day
Sold 36,642 shares at $106.31 ($3.9M)
Weitzman Deborah, CEO, Pharmaceutical Segment
10b5-1 planSold 51% of holdings ($7.6M position)35,202 shares leftFollows a Form 144Filing
- 5 Form 144 notice CAHNoticeAug 20, 2025 +632 days
Filed to sell 21,367 shares ($3.2M)
Weitzman Deborah, Officer
No 10b5-1 planFiling
- 6 Form 4 sale CAHUnusualAug 20, 2025 same day
Sold 21,367 shares at $150.53 ($3.2M)
Weitzman Deborah, CEO, PSS Segment
No 10b5-1 planSold 28.6% of holdings ($11.3M position)53,428 shares leftFollows a Form 144Filing
- 7 Form 144 notice CAHNoticeAug 18, 2026 +363 days
Filed to sell 7,354 shares ($1.7M)
Weitzman Deborah, Officer
No 10b5-1 planFiling
- 8 Form 4 sale CAHNo planAug 18, 2026 same day
Sold 7,354 shares at $235.45 ($1.7M)
Weitzman Deborah, CEO, PSS Segment
No 10b5-1 planSold 8.6% of holdings ($20.1M position)77,901 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Aug 20, 2026 | CAH | CEO, PSS Segment | Form 4 sale | 7,354 | $1.7M | 8.6% | No plan | SEC |
| Aug 18, 2026 | Aug 18, 2026 | CAH | Officer | Form 144 notice | 7,354 | $1.7M | Notice | SEC | |
| Aug 20, 2025 | Aug 20, 2025 | CAH | CEO, PSS Segment | Form 4 sale | 21,367 | $3.2M | 28.6% | Unusual | SEC |
| Aug 20, 2025 | Aug 20, 2025 | CAH | Officer | Form 144 notice | 21,367 | $3.2M | Notice | SEC | |
| Nov 27, 2023 | Nov 29, 2023 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 36,642 | $3.9M | 51.0% | Routine | SEC |
| Nov 27, 2023 | Nov 27, 2023 | CAH | Officer | Form 144 notice | 36,642 | $3.9M | Notice | SEC | |
| Aug 28, 2023 | Aug 29, 2023 | CAH | CEO, Pharmaceutical Segment | Form 4 sale | 6,712 | $603k | 13.2% | No plan | SEC |
| Aug 28, 2023 | Aug 28, 2023 | CAH | Officer | Form 144 notice | 6,712 | $603k | Notice | SEC |